ORLANDO, Fla., Nov. 20, 2019 (GLOBE NEWSWIRE) -- You don’t have to be the most astute market observer to see the CBD revolution at hand. CBD is omnipresent now, finding its way to virtually every product sector and is an open discussions across all media about its virtues and benefits. Frankly, the last market disruptor at the level of CBD might have been the Internet itself.
But all the blue sky for CBD was overshadowed for the past few months as the well-publicized vaping crisis tore at market support for CBD-based public companies. Most everyone who follows cannabis pubcos knows the vaping crisis has been extremely detrimental for cannabis/CBD in general and has been largely responsible for much of the sell-off of cannabis / CBD stocks so dramatically for the last 90 days. Opportunistic bears and short sellers on cannabis stocks have frightened investors with predictions of the end of the cannabis business based on the vaping scare.
And then an announcement last Friday by the U.S Government Center for Disease Control (CDC) clearly points out that the likely culprit in the vaping crisis was Vitamin E acetate and that the sources of the problem were almost always illicit or illegal. In a nutshell, nothing to do with CBD.
The news bodes well for CBD entrants like Earth Science Tech, Inc. (ETST), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development. It is compelling that Earth Science has real life science qualifications and isn’t just a new entry chasing the CBD gold rush. Earth Science is a real team of scientists and executives looking to officiate this opportunity.
A simple review of the company website also shows a pretty diversified CBD offering already on the market. From all appearances, this is an advanced CBD based company.
It’s also worth noting that that Company’s CBD products are made in a superior manner. Here’s a quick summary of what makes them different.
It’s worth digging a little deeper, reading the product sheet, and testing the management team too. It’s in this discovery that the real differentiators are often found.
And now with the spurious association to the vaping process appearing to be gone, CBD companies may have reached a critical turning point.
About Earth Science Tech Inc. (ETST)
Earth Science Tech Inc. (“ETST”) offers the highest purity and quality high-grade, full-spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, in addition to studies through DV Biologics that prove the Company’s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive-result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market. To learn more, please visit: www.EarthScienceTech.com. ETST currently has two wholly owned subsidiaries and a favored entity focused on developing its role as a world leader in the CBD space, expanding its work in the pharmaceutical and medical device sectors.
For more informative reports such as this, please sign up at http://www.emergingmarketsllc.com/newsletter.php
Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.
We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies.
EMC has been paid $5,000 per month plus 250,000 restricted shares on behalf of Earth Science Technology, Inc. for various marketing services including this report. EMC does not independently verify any of the content linked-to from this editorial. http://emergingmarketsllc.com/disclaimer.php